SEHK:241

Stock Analysis Report

NOT FOR DISTRIBUTION
Header cover image

Alibaba Health Information Technology

Executive Summary

Alibaba Health Information Technology Limited, an investment holding company, engages in the pharmaceutical e-commerce, intelligent medicine, and product tracking platform businesses in the People’s Republic of China. More Details


Snowflake Analysis

Flawless balance sheet with high growth potential.


Similar Companies

Share Price & News

How has Alibaba Health Information Technology's share price performed over time and what events caused price changes?


Latest Share Price and Events

Stable Share Price: 241 is not significantly more volatile than the rest of Hong Kong stocks over the past 3 months, typically moving +/- 8% a week.

Volatility Over Time: 241's weekly volatility (8%) has been stable over the past year.


Market Performance


7 Day Return

1.5%

241

0.5%

HK Healthcare Services

1.1%

HK Market


1 Year Return

140.5%

241

123.8%

HK Healthcare Services

8.3%

HK Market

Return vs Industry: 241 exceeded the Hong Kong Healthcare Services industry which returned 123.8% over the past year.

Return vs Market: 241 exceeded the Hong Kong Market which returned 8.3% over the past year.


Shareholder returns

241IndustryMarket
7 Day1.5%0.5%1.1%
30 Day-0.2%7.1%5.6%
90 Day14.6%11.6%3.7%
1 Year140.5%140.5%124.2%123.8%12.8%8.3%
3 Year406.2%406.2%293.0%290.2%-2.8%-12.9%
5 Year242.3%242.3%249.6%246.2%30.6%8.5%

Long-Term Price Volatility Vs. Market

How volatile is Alibaba Health Information Technology's share price compared to the market and industry in the last 5 years?


Simply Wall St News

Valuation

Is Alibaba Health Information Technology undervalued compared to its fair value and its price relative to the market?

39.23x

Price to Book (PB) ratio


Share Price vs. Fair Value

Below Fair Value: 241 (HK$20.3) is trading above our estimate of fair value (HK$12.59)

Significantly Below Fair Value: 241 is trading above our estimate of fair value.


Price To Earnings Ratio

PE vs Industry: 241 is unprofitable, so we can't compare its PE Ratio to the XA Healthcare Services industry average.

PE vs Market: 241 is unprofitable, so we can't compare its PE Ratio to the Hong Kong market.


Price to Earnings Growth Ratio

PEG Ratio: Insufficient data to calculate 241's PEG Ratio to determine if it is good value.


Price to Book Ratio

PB vs Industry: 241 is overvalued based on its PB Ratio (39.2x) compared to the XA Healthcare Services industry average (5.5x).


Next Steps

Future Growth

How is Alibaba Health Information Technology forecast to perform in the next 1 to 3 years based on estimates from 10 analysts?

44.6%

Forecasted annual earnings growth


Earnings and Revenue Growth Forecasts


Analyst Future Growth Forecasts

Earnings vs Savings Rate: 241 is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (1.6%).

Earnings vs Market: 241 is forecast to become profitable over the next 3 years, which is considered above average market growth.

High Growth Earnings: 241's is expected to become profitable in the next 3 years.

Revenue vs Market: 241's revenue (30.7% per year) is forecast to grow faster than the Hong Kong market (13.8% per year).

High Growth Revenue: 241's revenue (30.7% per year) is forecast to grow faster than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: 241's Return on Equity is forecast to be low in 3 years time (11.7%).


Next Steps

Past Performance

How has Alibaba Health Information Technology performed over the past 5 years?

25.3%

Historical annual earnings growth


Earnings and Revenue History

Quality Earnings: 241 is currently unprofitable.

Growing Profit Margin: 241 is currently unprofitable.


Past Earnings Growth Analysis

Earnings Trend: 241 is unprofitable, but has reduced losses over the past 5 years at a rate of 25.3% per year.

Accelerating Growth: Unable to compare 241's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: 241 is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare Services industry (-14.3%).


Return on Equity

High ROE: 241 has a negative Return on Equity (-0.3%), as it is currently unprofitable.


Next Steps

Financial Health

How is Alibaba Health Information Technology's financial position?


Financial Position Analysis

Short Term Liabilities: 241's short term assets (CN¥5.0B) exceed its short term liabilities (CN¥2.6B).

Long Term Liabilities: 241's short term assets (CN¥5.0B) exceed its long term liabilities (CN¥57.6M).


Debt to Equity History and Analysis

Debt Level: 241 is debt free.

Reducing Debt: 241 had no debt 5 years ago.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: Whilst unprofitable 241 has sufficient cash runway for more than 3 years if it maintains its current positive free cash flow level.

Forecast Cash Runway: 241 is unprofitable but has sufficient cash runway for more than 3 years, due to free cash flow being positive and growing by 47.2% per year.


Next Steps

Dividend

What is Alibaba Health Information Technology current dividend yield, its reliability and sustainability?


Dividend Yield vs Market

Notable Dividend: Unable to evaluate 241's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate 241's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.


Stability and Growth of Payments

Stable Dividend: Insufficient data to determine if 241's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if 241's dividend payments have been increasing.


Current Payout to Shareholders

Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: No need to calculate the sustainability of 241's dividend in 3 years as they are not forecast to pay a notable one for the Hong Kong market.


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?

0.6yrs

Average management tenure


CEO

Shunyan Zhu (49 yo)

0.67

Tenure

Mr. Shunyan Zhu serves as Chairman of the Board and Chief Executive Officer and Executive Director at Alibaba Health Information Technology Limited since March 16, 2020. He is the President of the Innovati...


Leadership Team

NamePositionTenureCompensationOwnership
Shunyan Zhu
Chairman of the Board & CEO0.67yrno datano data
Yanwu Tu
CFO & Executive Director0.083yrno data0.00029%
CN¥ 801.1k
Chun Chung Kwong
Financial Controllerno datano datano data
Wai Yan Lee
Company Secretary0.25yrno datano data

0.6yrs

Average Tenure

Experienced Management: 241's management team is not considered experienced ( 0.6 years average tenure), which suggests a new team.


Board Members

NamePositionTenureCompensationOwnership
Shunyan Zhu
Chairman of the Board & CEO0.67yrno datano data
Yanwu Tu
CFO & Executive Director0.083yrno data0.00029%
CN¥ 801.1k
Yongming Wu
Non-Executive Director5.58yrsno data0.0094%
CN¥ 25.9m
Chang Meng
Director of Alibaba Health Technology(Beijing) Company Limitedno datano datano data
Tong Luo
Independent Non-Executive Director6.5yrsCN¥306.00kno data
King On Wong
Independent Non-Executive Director6.5yrsCN¥565.00kno data
Li Ma
Director of Alibaba Health Technology(Beijing) Company Limitedno datano datano data
Peiyu Wang
Director of CITIC 21CN (China) Technology Company Limitedno datano datano data
Hong Xu
Non-Executive Director1.42yrsno datano data
Yi Fei Huang
Independent Non-Executive Director1.42yrsCN¥229.00kno data

1.4yrs

Average Tenure

47yo

Average Age

Experienced Board: 241's board of directors are not considered experienced ( 1.4 years average tenure), which suggests a new board.


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: 241 insiders have only sold shares in the past 3 months.


Recent Insider Transactions

Ownership Breakdown

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 11.9%.


Top Shareholders

Company Information

Alibaba Health Information Technology Limited's company bio, employee growth, exchange listings and data sources


Key Information

  • Name: Alibaba Health Information Technology Limited
  • Ticker: 241
  • Exchange: SEHK
  • Founded:
  • Industry: Health Care Technology
  • Sector: Healthcare
  • Market Cap: HK$276.255b
  • Shares outstanding: 13.44b
  • Website: https://www.alihealth.cn

Number of Employees


Location

  • Alibaba Health Information Technology Limited
  • Tower One
  • 26th Floor
  • Causeway Bay
  • Hong Kong

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
ALBH.FOTCPK (Pink Sheets LLC)YesOrdinary SharesUSUSDAug 1998
TWYDB (Deutsche Boerse AG)YesOrdinary SharesDEEURAug 1998
241SEHK (The Stock Exchange of Hong Kong Ltd.)YesOrdinary SharesHKHKDAug 1998
TWYBST (Boerse-Stuttgart)YesOrdinary SharesDEEURAug 1998
241SHSC (Stock Exchange of Hong Kong Limited - Shanghai - Hong Kong Stock Connect)YesOrdinary SharesHKHKDAug 1998
241SZSC (The Stock Exchange of Hong Kong - Shenzhen - Hong Kong Stock Connect)YesOrdinary SharesHKHKDAug 1998
ALBB.YOTCPK (Pink Sheets LLC)UNSPONSORD ADRUSUSDJul 2017

Biography

Alibaba Health Information Technology Limited, an investment holding company, engages in the pharmaceutical e-commerce, intelligent medicine, and product tracking platform businesses in the People’s Republ...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2020/11/23 12:47
End of Day Share Price2020/11/23 00:00
Earnings2020/03/31
Annual Earnings2020/03/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.